Affymetrix News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.10.11	Affymetrix Launches 18 New Microarrays for Gene Expression Analysis of Model and Applied Research Organisms (Businesswire)
28.02.11	Affymetrix® Launches Next-Generation microRNA Solution (Businesswire)
20.07.10	Cyclone Power Technologies Performs Combustion Tests of Gulf Crude Oil (Businesswire)
28.06.10	Signature Diagnostics to Use Affymetrix Microarray Technology for Advanced Colorectal Cancer Tests (Businesswire)
10.05.10	Progenics Pharmaceuticals Announces First Quarter 2010 Financial Results (Businesswire)
23.02.10	Affymetrix Announces Winner of Anatrace Membrane Protein Award (Businesswire)
01.09.09	Affymetrix to Webcast Presentations at September Financial Conferences (Businesswire)
29.05.09	Affymetrix Chief Medical Officer to speak at AAAS on Personalized Medicine (Businesswire)
28.01.09	Affymetrix Reports Fourth Quarter and Fiscal Year 2008 Results (Businesswire)
15.01.09	Coriell Institute for Medical Research Selects Affymetrix DMET Plus Product for National Personalized Medicine Project (Businesswire)
08.01.09	Affymetrix to Webcast Presentation at JPMorgan Healthcare Conference (Businesswire)
01.12.08	Researchers Use Affymetrix Technology to Discover Why Some Breast Cancer Patients Resist Tamoxifen (Businesswire)
11.11.08	Affymetrix to Acquire Panomics (Businesswire)
01.10.08	Affymetrix and Medical Prognosis Institute Collaborate to Develop Cancer Treatment Products (Businesswire)
24.07.08	Affymetrix Reports Second Quarter 2008 Results (Businesswire)
16.06.08	Center for Inherited Disease Research Adds Affymetrix Platform for Large-Scale Genotyping Services (Businesswire)
30.05.08	Affymetrix Technology Powers First Genomic Tumor Grading Test for Breast Cancer (Businesswire)
19.05.08	Korea NIH Expands KARE Project with Second Affymetrix Technology Order (Businesswire)
12.05.08	LineaGen Selects Affymetrix Technology to Discover Genes Associated With Autism and Multiple Sclerosis (Businesswire)
24.01.08	Clinical Data and Affymetrix Announce Marketing Agreement for New Drug Metabolism Service (Businesswire)
17.12.07	Affymetrix Simplifies Copy Number Data Analysis for Association and Cytogenetic Studies (Businesswire)
13.12.07	Canada's Leading Cardiovascular Center Uses Affymetrix SNP Array 6.0 to Replicate Whole-genome Association Study Findings (Businesswire)
13.11.07	Affymetrix Announces Proposed $250 Million Offering of Senior Convertible Notes Due 2038 (Businesswire)
01.10.07	Affymetrix Hosts Two Cancer Genomics Workshops at 2007 NCRI Conference (Businesswire)
18.09.07	Affymetrix Promotes Kevin King to Company President (Businesswire)
17.09.07	Affymetrix Hosts Pharmacogenetics Workshop at Discovery 2 Diagnostics Conference (Businesswire)
29.08.07	Affymetrix to Webcast Presentations at Two September Financial Conferences (Businesswire)
01.08.07	Dr. Lubert Stryer Awarded 2006 National Medal of Science (Businesswire)
19.07.07	The Wellcome Trust Case Control and Cardiogenics Consortiums Identify Key Genes in Coronary Artery Disease with Affymetrix Technology (Businesswire)
17.07.07	Affymetrix and Children's Research Institute Form Five-year Strategic Alliance (Businesswire)
16.07.07	Affymetrix Clinical Services Laboratory and DOCRO Join Forces to Accelerate the Commercialization of In Vitro Diagnostic Products (Businesswire)
09.07.07	Affymetrix Launches European Cytogenetic Research Initiative (Businesswire)
16.04.07	Affymetrix Launches Program to Advance Cancer Research (Businesswire)
27.06.06	Epigenomics AG and Affymetrix Announce Strategic Diagnostics Platform Agreement (Businesswire)
09.01.06	Duke University and Affymetrix Initiate Five-Year Translational Research Collaboration (Businesswire)
04.04.05	Perlegen Sciences to Analyze Plague-Causing Bacteria with Biodefense G (Businesswire)
23.02.05	Perlegen and Johns Hopkins Awarded Grant for Comprehensive Mutational (Businesswire)
16.02.05	The University of Cambridge, Cancer Research Technology, Cancer Resear (Businesswire)
07.02.05	Affymetrix and Stratagene Announce Strategic Software Alliance (Businesswire)
07.02.05	Worldwide Public-Private Support Enables Perlegen Sciences to Expand I (Businesswire)
24.01.05	Perlegen Signs New Agreement with AstraZeneca (Businesswire)
11.01.05	Perlegen Sciences to Collaborate on Pharmacogenomics Study with Johnso (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	81.32	2.01 %	K V
Alcon	79.46	1.90 %	K V
Sonova Hldg	308.90	1.55 %	K V
ABB	51.64	1.29 %	K V
Lonza Grp	570.20	1.24 %	K V
Kuehne+Nagel Int	206.80	0.05 %	K V
Givaudan	3’960.00	-0.08 %	K V
Sika	227.00	-0.09 %	K V
Geberit	505.40	-0.20 %	K V
UBS Group	31.54	-0.66 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Affymetrix Inc.

Aktien Top/Flop

Meistgelesene Nachrichten